| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.08B | 1.12B | 1.27B | 1.48B | 1.02B | 662.30M |
| Gross Profit | 317.30M | 336.10M | 390.80M | 402.30M | 324.60M | 208.10M |
| EBITDA | -13.80M | -100.90M | 66.90M | 91.90M | 140.60M | 111.80M |
| Net Income | -231.20M | -264.40M | -108.00M | -91.80M | -12.40M | 2.80M |
Balance Sheet | ||||||
| Total Assets | 1.34B | 1.33B | 1.63B | 1.87B | 1.64B | 1.35B |
| Cash, Cash Equivalents and Short-Term Investments | 94.00M | 77.60M | 94.80M | 93.30M | 273.60M | 348.80M |
| Total Debt | 1.31B | 975.50M | 934.80M | 1.20B | 984.70M | 834.80M |
| Total Liabilities | 1.76B | 1.60B | 1.65B | 1.75B | 1.44B | 1.15B |
| Stockholders Equity | -411.80M | -273.10M | -22.20M | 119.00M | 202.60M | 208.20M |
Cash Flow | ||||||
| Free Cash Flow | -61.70M | -79.40M | -7.30M | -10.50M | 14.80M | 29.00M |
| Operating Cash Flow | 4.80M | -2.20M | 55.20M | 89.10M | 68.10M | 57.50M |
| Investing Cash Flow | -50.70M | -32.00M | -38.10M | -218.60M | -188.60M | -45.70M |
| Financing Cash Flow | 52.30M | 16.90M | -17.90M | -41.10M | 30.40M | 163.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £56.56M | 3.42 | 20.89% | 0.55% | 2.64% | 23.89% | |
68 Neutral | £37.21M | 6.55 | 8.41% | 11.65% | -3.45% | -44.02% | |
64 Neutral | £31.89M | 7.91 | 8.31% | 7.98% | -3.45% | -35.25% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | £39.75M | 9.31 | -22.13% | 3.45% | -4.23% | -435.86% | |
48 Neutral | £12.48M | -1.63 | 0.16% | ― | -3.72% | ― | |
43 Neutral | £36.91M | -0.14 | 67.51% | ― | -9.72% | 10.94% |